HitHealth Completes Series A Funding Round of Over RMB 10 Million, Making Whole-Brain Imaging a Reality

Investment Circle (ID: pedaily2012) reported on September 1 that, according to Arterial Network, Danyang Huichuang Medical Equipment Co., Ltd. (hereinafter referred to as “Huichuang Medical”) announced the completion of its Series A financing, amounting to tens of millions of yuan. This round of financing was led byQingyuan InvestmentLead investor. The funds raised in this round will be primarily used for R&D investment, market expansion, and supplementing working capital.

Huichuang Medical specializes in research on near-infrared brain imaging and assessment. The company has undertaken multiple national-level projects, including those under the National Key R&D Program. Its products have been demonstrated and applied in more than 60 authoritative Grade A tertiary hospitals and research institutions. In addition to serving as high-end equipment for clinical examination and evaluation, Huichuang’s products function as a premium platform for brain functional imaging research, supporting user institutions in publishing over 20 SCI-indexed papers. The high quality of its products has been widely recognized by experts both domestically and internationally.

In China, nearly 100 million people suffer from brain functional disorders such as cerebral palsy, attention deficit disorders in children, epilepsy, stroke, Parkinson’s disease, cognitive impairment, Alzheimer’s disease, and mental illnesses, with the incidence rate rising year by year. For a long time, there has been a lack of effective quantitative techniques for assessing brain function in these patients under naturalistic conditions.Near-infrared brain imaging, as a new generation of quantitative functional brain imaging technology, offers the advantage of greater flexibility in application scenarios compared to techniques such as functional magnetic resonance imaging (fMRI). It enables high-resolution quantitative assessment and evaluation of brain function while patients are moving, speaking, or undergoing treatment, thereby providing unprecedented technical means for the diagnosis and treatment of brain disorders.

Chief Scientist, Founder, and Chairman of Huichuang MedicalDr. Wang Daifa has dedicated over a decade to research in near-infrared brain imaging. He has led national-level projects, including the National Major Scientific Instrument Development Project, the National Key R&D Program, and projects funded by the National Natural Science Foundation of China. Dr. Wang has received numerous honors, such as the Jiangsu Shuangchuang Talent, Zhenjiang Jinshan Elite Talent, Beihang University Young Top-notch Talent, First Prize for Outstanding Doctoral Dissertation at Tsinghua University, and Outstanding Undergraduate Thesis Award at Tsinghua University. The high-performance near-infrared brain imaging product developed under his leadership boasts world-leading core metrics and is the first ultra-high-channel (>100 channels) near-infrared brain imaging system (NirScan) to receive NMPA medical device registration certification globally, making whole-brain imaging possible.